menu toggle
As we continue to evolve our brand to Cencora, you will continue to see visual changes. We will be sunsetting amerisourcebergen.com over time and are actively moving content and information over to cencora.com. Please visit cencora.com if you can't find what you are looking for here.

Nine questions about rare and orphan drug commercialization

By AmerisourceBergen

Set your product up to reach patients in need
Patients should be at the center of strategies to commercialize rare and orphan disease treatments. Enter your information below to read more about what questions to consider to set your product up for maximum reach and impact.